1.64
-0.12(-6.82%)
Currency In USD
Previous Close | 1.76 |
Open | 1.73 |
Day High | 1.77 |
Day Low | 1.63 |
52-Week High | 2.72 |
52-Week Low | 0.85 |
Volume | 7.13M |
Average Volume | 7.18M |
Market Cap | 492.61M |
PE | -0.74 |
EPS | -2.23 |
Moving Average 50 Days | 1.34 |
Moving Average 200 Days | 1.36 |
Change | -0.12 |
If you invested $1000 in Pacific Biosciences of California, Inc. (PACB) 10 years ago, it would be worth $215.79 as of October 19, 2025 at a share price of $1.64. Whereas If you bought $1000 worth of Pacific Biosciences of California, Inc. (PACB) shares 5 years ago, it would be worth $109.7 as of October 19, 2025 at a share price of $1.64.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities
GlobeNewswire Inc.
Oct 14, 2025 10:05 AM GMT
New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than $300 at scaleMENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, t
PacBio HiFi Technology Selected as Core Platform for South Korea’s National Pangenome Project
GlobeNewswire Inc.
Oct 13, 2025 1:05 PM GMT
More than 1,000 Korean genomes to be sequenced for global reference standards, advancing disease research and precision medicineMENLO PARK, Calif. and SEOUL, South Korea, Oct. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer o
Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
GlobeNewswire Inc.
Oct 08, 2025 1:05 PM GMT
Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to dateMENLO PARK, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-q